🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchInsulin icodec (Awiqli) — need advice Page 7

Insulin icodec (Awiqli) — need advice

VendorMark Mon, Feb 2, 2026 at 1:53 AM 31 replies 1,494 viewsPage 7 of 7
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Feb 11, 2026 at 10:51 AM#31

The figures, for anyone assembling their own picture. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

Ask again with the specifics and you will get a better answer than this one.

Last edited: Feb 11, 2026 at 4:51 PM
32 5MikeFit_NJ, InsuranceTom, WendyG_ATL and 29 others
Reply Quote Save Share Report
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Feb 12, 2026 at 2:13 AM#32

One thing that is still open after jim_asheville’s answer:

What did you change at the same time, and can you separate the two now?

33 6stefan_berlin, Dr.EM_Chicago, pete_RVA and 30 others
Reply Quote Save Share Report
nick_newbie
New Member
18
56
Jun 2026
Virginia
Online
Feb 12, 2026 at 5:35 PM#33
Dr.PathRoch said:
Practical: whatever you change, write down the date and the reason.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

34 7MeganSA_TX, LarryQC_SD, wanda_boise and 31 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Feb 13, 2026 at 8:56 AM#34
Dr.PathRoch said:
Practical: whatever you change, write down the date and the reason.

That holds where the measurement is reliable. Where it is noisy — and a lot of what gets tracked here is noisy — the same reasoning produces confident nonsense.

Last edited: Feb 13, 2026 at 9:56 AM
35 8chris_chi24, tampaLisa73, KarenAZ_mom and 32 others
Reply Quote Save Share Report
wei_SG
Member
234
890
Nov 2024
Singapore, SG
Feb 14, 2026 at 12:17 AM#35
Dr.PathRoch said:
Practical: whatever you change, write down the date and the reason.

Genuinely useful, thank you. I had the facts and not the framework. Printing the relevant bit and taking it with me.

Last edited: Feb 14, 2026 at 1:17 AM
36 9JenPlateau, SallyK_inj, CryptoCarl and 33 others
Reply Quote Save Share Report
1567

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register